Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin and endothelial function in coronary artery disease with early type 2 diabetes
2013-000330-35Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of linagliptin in type 2 diabetes mellitus (T2DM) and coronary arteriosclerosis, sponsored by Medical University of Graz. Primary endpoint: Change in endothelial function. Started Apr 2013; status: completed.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)coronary arteriosclerosis
Beyond the preview
Go deeper on 2013-000330-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000330-35.